Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.4B | 20.1B | 20.7B | 23.8B |
Cost of revenue | 15.6B | 14.0B | 14.4B | 16.2B |
Gross profit | 6.8B | 6.1B | 6.3B | 7.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.9B | 3.3B | 3.3B | 3.6B |
Operating income | 979.1M | 968.7M | 1.3B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 478.8M | 434.5M | 447M | 458.6M |
Other income expense | — | — | — | — |
Pretax income | 585.5M | 556.7M | 875M | 1.8B |
Tax provision | 155.4M | 147.3M | 231.8M | 450.4M |
Net income | 430.1M | 409.4M | 643.2M | 1.3B |
Basic EPS | — | 1.8 | 2.9 | 5.9 |
Diluted EPS | — | 1.8 | 2.9 | 5.9 |
Basic average shares | — | 222.5M | 222.6M | 222.8M |
Diluted average shares | — | 222.5M | 222.6M | 222.8M |
EBITDA | 2.3B | 2.2B | 2.5B | 3.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |